Consistent with this, heterozygous oncogenic K-Ras mutations induce lung AD/ADC in the absence of p53 mutation [16], and loss of p53 does not have a significant impact on early K-Ras-induced lung tumorigenesis [17]. Here, KRAS is linked to Alzheimer disease.